How to buy BiondVax Pharmaceuticals stock | $3.03

BiondVax Pharmaceuticals Ltd is a biotechnology business based in the US. BiondVax Pharmaceuticals shares (BVXV) are listed on the NASDAQ and all prices are listed in US Dollars. BiondVax Pharmaceuticals employs 21 staff and has a market cap (total outstanding shares value) of 0.00.

BiondVax Pharmaceuticals stock price (NASDAQ: BVXV)

Use our graph to track the performance of BVXV stocks over time.

BiondVax Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$3.03
52-week range	$2.28 - $43.57
50-day moving average	$2.91
200-day moving average	$3.62
Wall St. target price	$81.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-2.30

Buy BiondVax Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy BiondVax Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of BiondVax Pharmaceuticals Ltd by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BiondVax Pharmaceuticals price performance over time

Historical closes compared with the close of $3.03 from 2021-05-28

1 week (2021-07-24)	N/A
1 month (2021-07-02)	8.21%
3 months (2021-05-04)	0.33%
6 months (2021-01-31)	N/A

1 year (2020-07-31)	N/A
2 years (2019-07-31)	N/A
3 years (2018-07-31)	N/A
5 years (2016-07-31)	N/A

BiondVax Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	5.31%
Return on equity TTM	0%
Profit margin	0%
Book value	$0.61
Market capitalisation	$41.8 million

TTM: trailing 12 months

Shorting BiondVax Pharmaceuticals shares

There are currently 402,553 BiondVax Pharmaceuticals shares held short by investors – that's known as BiondVax Pharmaceuticals's "short interest". This figure is 9.7% up from 366,965 last month.

There are a few different ways that this level of interest in shorting BiondVax Pharmaceuticals shares can be evaluated.

BiondVax Pharmaceuticals's "short interest ratio" (SIR)

BiondVax Pharmaceuticals's "short interest ratio" (SIR) is the quantity of BiondVax Pharmaceuticals shares currently shorted divided by the average quantity of BiondVax Pharmaceuticals shares traded daily (recently around 64927.903225806). BiondVax Pharmaceuticals's SIR currently stands at 6.2. In other words for every 100,000 BiondVax Pharmaceuticals shares traded daily on the market, roughly 6200 shares are currently held short.

However BiondVax Pharmaceuticals's short interest can also be evaluated against the total number of BiondVax Pharmaceuticals shares, or, against the total number of tradable BiondVax Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BiondVax Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 BiondVax Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0288% of the tradable shares (for every 100,000 tradable BiondVax Pharmaceuticals shares, roughly 29 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against BiondVax Pharmaceuticals.

Find out more about how you can short BiondVax Pharmaceuticals stock.

BiondVax Pharmaceuticals share dividends

We're not expecting BiondVax Pharmaceuticals to pay a dividend over the next 12 months.

BiondVax Pharmaceuticals share price volatility

Over the last 12 months, BiondVax Pharmaceuticals's shares have ranged in value from as little as $2.28 up to $43.5685. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BiondVax Pharmaceuticals's is 2.2508. This would suggest that BiondVax Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

BiondVax Pharmaceuticals overview

BiondVax Pharmaceuticals Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. .

Frequently asked questions

What percentage of BiondVax Pharmaceuticals is owned by insiders or institutions?
Currently 29.821% of BiondVax Pharmaceuticals shares are held by insiders and 2.041% by institutions. How many people work for BiondVax Pharmaceuticals?
Latest data suggests 21 work at BiondVax Pharmaceuticals. When does the fiscal year end for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals's fiscal year ends in December. Where is BiondVax Pharmaceuticals based?
BiondVax Pharmaceuticals's address is: Jerusalem BioPark Building, Jerusalem, Israel, 7414002 What is BiondVax Pharmaceuticals's ISIN number?
BiondVax Pharmaceuticals's international securities identification number is: US09073Q1058 What is BiondVax Pharmaceuticals's CUSIP number?
BiondVax Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 09073Q105